Q702 for the Treatment of Patients With Hematologic Malignancies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Q702 for the Treatment of Patients With Hematologic Malignancies — Stella

Home/Hematopoietic and Lymphatic System Neoplasm/

View on ClinicalTrials.gov

Recruiting

Back to Hematopoietic and Lymphatic System Neoplasm trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

Mayo Clinic in Arizona, Scottsdale, Arizona

Mayo Clinic in Rochester, Rochester, Minnesota

Key details

Phase

Early testing

Sponsor

Mayo Clinic

Enrollment target

~46 participants

Started

August 2025

Primary completion

September 2030

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.